Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Biospecifics Technologies Corp (NASDAQ:BSTC)

52.00
Delayed Data
As of 4:00pm ET
 +2.15 / +4.31%
Today’s Change
30.70
Today|||52-Week Range
52.58
+21.01%
Year-to-Date
No recent news for Biospecifics Technologies Corp.

Today’s Trading

Previous close49.85
Today’s open50.41
Day’s range50.20 - 52.58
Volume53,196
Average volume (3 months)51,372
Market cap$356.3M
Dividend yield--
Data as of 4:00pm ET, 12/09/2016

Growth & Valuation

Earnings growth (last year)+100.00%
Earnings growth (this year)+17.42%
Earnings growth (next 5 years)+38.00%
Revenue growth (last year)+61.61%
P/E ratio34.2
Price/Sales13.74
Price/Book7.70

Competitors

 Today’s
change
Today’s
% change
CDXSCodexis Inc-0.10-1.98%
PRTOProteon Therapeutics...+0.10+1.01%
RGNXRegenxbio Inc+0.70+3.35%
AVXLAnavex Life Sciences...+0.12+2.84%
Data as of 4:00pm ET, 12/09/2016

Financials

Next reporting dateMarch 17, 2017
EPS forecast (this quarter)$0.38
Annual revenue (last year)$22.8M
Annual profit (last year)$9.6M
Net profit margin42.28%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, CEO, CFO, Director &
CAO
Thomas L. Wegman
Controller
James Goris
Corporate headquarters
Lynbrook, New York

Forecasts


Search for Jobs